Citation Impact
Citing Papers
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
MicroRNA-mediated gene regulation and the resilience of multicellular animals
2024 StandoutNobel
The miR‐379/miR‐410 cluster at the imprinted Dlk1‐Dio3 domain controls neonatal metabolic adaptation
2014
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy
2017
Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
2017
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
2021
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy
2021
Myeloid-derived suppressor cells coming of age
2018 Standout
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
2012
Fast, sensitive and accurate integration of single-cell data with Harmony
2019 Standout
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
2016
Molecular mechanisms regulating NLRP3 inflammasome activation
2015 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Metazoan MicroRNAs
2018 Standout
Clinical trials with anti-angiogenic agents in hematological malignancies
2010
Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation
2014
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Targeting B Cells and Antibody in Transplantation
2011
B Cells, Antibodies, and More
2015
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes
2016
The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes
2015
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment
2014
MicroRNAs as stress regulators in pancreatic beta cells and diabetes
2017
Type 2 diabetes mellitus
2015 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Comprehensive Integration of Single-Cell Data
2019 Standout
Phenotypic screening in cancer drug discovery — past, present and future
2014
Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma
2012
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
MicroRNAs in islet hormone secretion
2018
Negative regulation of the inflammasome: keeping inflammation under control
2015
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
2014
Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies
2010
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
2018
Lenalidomide efficacy in activated B ‐cell‐like subtype diffuse large B ‐cell lymphoma is dependent upon IRF 4 and cereblon expression
2012
Works of Kumar Vivek being referenced
Mechanism of action of lenalidomide in hematological malignancies
2009
Underutilization of A2 ABO incompatible kidney transplantation
2011
Epigenetic Regulation of the DLK1-MEG3 MicroRNA Cluster in Human Type 2 Diabetic Islets
2014
B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation
2010
Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFF
2012